FDA Approves Bimonthly HIV Prevention Shot More Effective Than Existing PrEP Medications

The US Food and Drug Administration (FDA) federal regulatory agency has approved Apretude as the nation’s first injectable pre-exposure prophylaxis (PrEP), a medication that prevents infection from Human Immunodeficiency Virus (HIV).